IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)          Journal is Currently Not Indexed in Scopus as on february 2021 list provided by scopus

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Procalcitonin, IL-1ß, HSP10 and Resolvin D2 Mechanism as Sepsis Biomarkers in Sepsis Model

Author: MUHAMMAD AFRIJANTO, USMAN HADI, YOES PRIJATNA DACHLAN
Abstract: Background: The use of various biomarkers in sepsis has an important role in helping diagnosis and decision making therapy quickly and accurately. This study aimed to explain the mechanism of procalcitonin, IL-1ß, RAMPs markers such as HSP10 and resolvin D2 as biomarkers of sepsis in the sepsis model of Eschericia coli infection given with meropenem antibiotics. Methods: An experimental study using the E. coli sepsis model in male Rattus norvegicuswas conducted in 2 stages. The first step was to observe a model of sepsis in rats and determine the time of sepsis and the second step was to compare levels of procalcitonin, HSP10, IL-1ß, and resolvin D2 with different dosage of germs and different antibiotic time of administration. Results: The time of sepsis was occurred between 8 and 10 hours. There were differences in E. coli exposure with IL-1ß levels (p = 0.03), procalcitonin (p = 0.084), HSP10 (p = 0.000), and resolvin D2 (p = 0.024). There were differences in levels of procalcitonin and resolvin D2 between groups at 24, 48 and 72 hours and between the treatment of antibiotics at different times and without antibiotic administration. While there were differences the levels of IL-1ß and HSP10 between groups at 24 and 72 hours, but there was no difference at 48 hours antibiotic treatments. Conclusion: Resolvin D2 and HSP10 have a slightly different pattern at 24 and 72 hours compared to procalcitonin and HSP10. Thus, it has the potential to be developed as a new biomarker in sepsis.
Keyword: sepsis, biomarker, Procalcitonin, IL-1ß, HSP10, Resolvin D2
DOI: https://doi.org/10.31838/ijpr/2020.12.04.194
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free